Janiczek Wealth Management LLC Cuts Position in CVS Health Co. (NYSE:CVS)

Janiczek Wealth Management LLC lowered its position in CVS Health Co. (NYSE:CVSFree Report) by 45.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 954 shares of the pharmacy operator’s stock after selling 799 shares during the quarter. Janiczek Wealth Management LLC’s holdings in CVS Health were worth $66,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of CVS. Live Oak Investment Partners acquired a new stake in CVS Health in the fourth quarter valued at $25,000. Freedom Wealth Alliance LLC purchased a new position in CVS Health during the 4th quarter valued at about $40,000. True Wealth Design LLC purchased a new stake in shares of CVS Health in the fourth quarter valued at about $48,000. 25 LLC acquired a new stake in shares of CVS Health in the first quarter valued at approximately $39,000. Finally, General Partner Inc. acquired a new position in shares of CVS Health during the 1st quarter worth approximately $47,000. 75.99% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CVS Health

In other CVS Health news, SVP James David Clark sold 25,759 shares of the company’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $74.92, for a total transaction of $1,929,864.28. Following the sale, the senior vice president now owns 4,698 shares in the company, valued at $351,974.16. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Wolfe Research raised CVS Health from a “peer perform” rating to an “outperform” rating and set a $80.00 price target for the company in a research report on Tuesday, September 12th. Morgan Stanley cut their target price on shares of CVS Health from $120.00 to $110.00 and set an “overweight” rating for the company in a research note on Thursday, August 3rd. Raymond James lowered their price target on shares of CVS Health from $90.00 to $85.00 and set an “outperform” rating for the company in a report on Friday, August 4th. Cantor Fitzgerald restated an “overweight” rating and set a $87.00 target price on shares of CVS Health in a research report on Thursday. Finally, JPMorgan Chase & Co. lowered their price target on CVS Health from $114.00 to $106.00 in a report on Friday, July 7th. Three investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $96.00.

View Our Latest Research Report on CVS Health

CVS Health Stock Performance

CVS Health stock opened at $70.87 on Monday. The company has a debt-to-equity ratio of 0.84, a current ratio of 0.86 and a quick ratio of 0.64. The firm’s fifty day moving average price is $70.83 and its 200 day moving average price is $71.77. The company has a market capitalization of $91.03 billion, a price-to-earnings ratio of 31.08, a price-to-earnings-growth ratio of 1.33 and a beta of 0.63. CVS Health Co. has a 12-month low of $64.62 and a 12-month high of $104.83.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings results on Wednesday, August 2nd. The pharmacy operator reported $2.21 EPS for the quarter, topping the consensus estimate of $2.12 by $0.09. CVS Health had a return on equity of 15.43% and a net margin of 0.86%. The business had revenue of $88.92 billion for the quarter, compared to analysts’ expectations of $86.41 billion. During the same quarter in the previous year, the firm posted $2.40 earnings per share. The company’s revenue was up 10.3% compared to the same quarter last year. On average, research analysts forecast that CVS Health Co. will post 8.61 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, August 1st. Stockholders of record on Friday, July 21st were paid a $0.605 dividend. The ex-dividend date of this dividend was Thursday, July 20th. This represents a $2.42 dividend on an annualized basis and a dividend yield of 3.41%. CVS Health’s dividend payout ratio (DPR) is presently 106.14%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Featured Articles

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.